Skip to Main Content

6,833

Views

15

CrossRef citations to date

0

Altmetric

Reports

Preclinical characterization of dostarlimab, a therapeutic anti-PD-1 antibody with potent activity to enhance immune function in in vitro cellular assays and in vivo animal models

Sujatha Kumara Translational Research, Immuno-Oncology, Checkmate Pharmaceuticals, Cambridge, MA, USACorrespondence[email protected]
View further author information

,

Srimoyee Ghoshb Oncology Experimental Medicine Unit, GlaxoSmithKline, Waltham, MA, USAView further author information

,

Geeta Sharmac Synthetic Lethal Research Unit, Oncolog, GlaxoSmithKline, Waltham, MA, USAView further author information

,

Zebin Wangd Translational Strategy & Research, GlaxoSmithKline,Waltham, MA, USAView further author information

,

Marilyn R. Kehrye Cell Biology, AnaptysBio, Inc,San Diego, CA, USAView further author information

,

Margaret H. Marinof Program Management, AnaptysBio, Inc, San Diego, CA, USAView further author information

,

Tamlyn Y. Nebenf Program Management, AnaptysBio, Inc, San Diego, CA, USAView further author information

,

Sharon Lug Clinical Pharmacology, Scholar Rock, Cambridge, MA, USAView further author information

,

Shouqi Luoh Toxicology, Atea Pharmaceuticals, Boston, MA, USAView further author information

,

Simon Robertsi Nonclinical Development, Research In Vivo/In Vitro Translation, GlaxoSmithKline, Waltham, MA, USAView further author information

,

Sridhar Ramaswamyj Google Ventures, Cambridge, MA, USAView further author information

,

Hadi Danaeek Translational Medicine, Blue Print Medicines, Cambridge, MA, USAView further author information

&

David Jenkinsl External Innovations, IPSEN, Cambridge, MA, USAView further author information